• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三氯生抗疟类似物组合文库的设计及其对恶性疟原虫烯酰-酰基载体蛋白还原酶抑制作用的计算机模拟筛选

Design and in silico screening of combinatorial library of antimalarial analogs of triclosan inhibiting Plasmodium falciparum enoyl-acyl carrier protein reductase.

作者信息

Frecer Vladimir, Megnassan Eugene, Miertus Stanislav

机构信息

International Centre for Science and High Technology, UNIDO, Trieste, Italy.

出版信息

Eur J Med Chem. 2009 Jul;44(7):3009-19. doi: 10.1016/j.ejmech.2008.12.028. Epub 2009 Jan 19.

DOI:10.1016/j.ejmech.2008.12.028
PMID:19217192
Abstract

Enoyl-acyl carrier protein reductase of Plasmodium falciparum (PfENR) is an important target for antimalarial agents that interfere with the FAS-II pathway of lipid synthesis, which is specific for the parasite. Recent studies showed that substituted analogs of triclosan (TCL) inhibit the purified PfENR enzyme with IC(50) values below 200 nM when the suboptimal 5-chloro group was replaced by larger hydrophobic moieties. We have used computer-assisted combinatorial techniques to design, focus and in silico screen a virtual library of TCL analogs substituted at positions 5, 4' and 2'. Our study can thus direct synthetic chemists working on the antimalarial FAS-II inhibitors towards the explored subset of the chemical space, which is predicted to contain compounds with PfENR inhibition potencies in the low nanomolar range and favorable ADME properties.

摘要

恶性疟原虫的烯酰-酰基载体蛋白还原酶(PfENR)是干扰脂质合成FAS-II途径的抗疟药物的重要靶点,该途径是该寄生虫所特有的。最近的研究表明,当次优的5-氯基团被更大的疏水部分取代时,三氯生(TCL)的取代类似物能以低于200 nM的IC(50)值抑制纯化的PfENR酶。我们利用计算机辅助组合技术设计、聚焦并在计算机上筛选了在5、4'和2'位取代的TCL类似物虚拟库。因此,我们的研究可以引导致力于抗疟FAS-II抑制剂的合成化学家朝着化学空间中已探索的子集方向进行研究,预计该子集中含有低纳摩尔范围内具有PfENR抑制效力且具有良好药代动力学性质的化合物。

相似文献

1
Design and in silico screening of combinatorial library of antimalarial analogs of triclosan inhibiting Plasmodium falciparum enoyl-acyl carrier protein reductase.三氯生抗疟类似物组合文库的设计及其对恶性疟原虫烯酰-酰基载体蛋白还原酶抑制作用的计算机模拟筛选
Eur J Med Chem. 2009 Jul;44(7):3009-19. doi: 10.1016/j.ejmech.2008.12.028. Epub 2009 Jan 19.
2
Design, development, synthesis, and docking analysis of 2'-substituted triclosan analogs as inhibitors for Plasmodium falciparum enoyl-ACP reductase.设计、开发、合成 2'-取代三氯生类似物并进行对接分析,作为疟原虫烯酰基-ACP 还原酶抑制剂。
IUBMB Life. 2009 Nov;61(11):1083-91. doi: 10.1002/iub.258.
3
Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 1: 4'-substituted triclosan derivatives.疟疾烯酰酰基载体蛋白还原酶的二芳基醚抑制剂的合成、生物活性及X射线晶体结构分析。第1部分:4'-取代的三氯生衍生物。
Bioorg Med Chem Lett. 2005 Dec 1;15(23):5247-52. doi: 10.1016/j.bmcl.2005.08.044. Epub 2005 Sep 29.
4
Synthesis and biological activity of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 2: 2'-substituted triclosan derivatives.疟疾烯酰酰基载体蛋白还原酶的二芳基醚抑制剂的合成及生物活性。第2部分:2'-取代的三氯生衍生物。
Bioorg Med Chem Lett. 2006 Apr 15;16(8):2163-9. doi: 10.1016/j.bmcl.2006.01.051. Epub 2006 Feb 8.
5
3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors.三氯生衍生物作为恶性疟原虫烯酰基辅酶 A 还原酶抑制剂的 3D-QSAR 研究。
SAR QSAR Environ Res. 2010 Jul;21(5-6):527-45. doi: 10.1080/1062936X.2010.502297.
6
SAR and pharmacophore models for the rhodanine inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase.疟疾滋养体烯酰基辅酶 A 还原酶抑制剂类噻唑烷酮的 SAR 和药效团模型。
IUBMB Life. 2010 Mar;62(3):204-13. doi: 10.1002/iub.306.
7
Epigallocatechin gallate is a slow-tight binding inhibitor of enoyl-ACP reductase from Plasmodium falciparum.表没食子儿茶素没食子酸酯是恶性疟原虫烯酰-ACP还原酶的一种缓慢紧密结合型抑制剂。
Biochem Biophys Res Commun. 2008 Dec 26;377(4):1238-42. doi: 10.1016/j.bbrc.2008.10.135. Epub 2008 Nov 4.
8
Discovery of a rhodanine class of compounds as inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase.发现一类若丹宁化合物可作为恶性疟原虫烯酰-酰基载体蛋白还原酶的抑制剂。
J Med Chem. 2007 May 31;50(11):2665-75. doi: 10.1021/jm061257w. Epub 2007 May 4.
9
Structure-Based Design and Pharmacophore-Based Virtual Screening of Combinatorial Library of Triclosan Analogues Active against Enoyl-Acyl Carrier Protein Reductase of with Favourable ADME Profiles.基于结构的设计和基于药效团的虚拟筛选三氯生类似物组合文库对酰基辅酶 A 还原酶的活性与有利的 ADME 概况。
Int J Mol Sci. 2023 Apr 7;24(8):6916. doi: 10.3390/ijms24086916.
10
Structural basis for triclosan and NAD binding to enoyl-ACP reductase of Plasmodium falciparum.三氯生和烟酰胺腺嘌呤二核苷酸与恶性疟原虫烯酰-ACP还原酶结合的结构基础。
Biochem Biophys Res Commun. 2001 Apr 27;283(1):224-8. doi: 10.1006/bbrc.2001.4747.

引用本文的文献

1
Application of Machine Learning in the Development of Fourth Degree Quantitative Structure-Activity Relationship Model for Triclosan Analogs Tested against 3D7.机器学习在三氯生类似物针对3D7测试的四阶定量构效关系模型开发中的应用。
ACS Omega. 2024 Oct 25;9(44):44436-44447. doi: 10.1021/acsomega.4c05768. eCollection 2024 Nov 5.
2
Structure-Based Design and Pharmacophore-Based Virtual Screening of Combinatorial Library of Triclosan Analogues Active against Enoyl-Acyl Carrier Protein Reductase of with Favourable ADME Profiles.基于结构的设计和基于药效团的虚拟筛选三氯生类似物组合文库对酰基辅酶 A 还原酶的活性与有利的 ADME 概况。
Int J Mol Sci. 2023 Apr 7;24(8):6916. doi: 10.3390/ijms24086916.
3
Antiviral agents against COVID-19: structure-based design of specific peptidomimetic inhibitors of SARS-CoV-2 main protease.
抗2019冠状病毒病的抗病毒药物:基于结构设计的严重急性呼吸综合征冠状病毒2主蛋白酶特异性拟肽抑制剂
RSC Adv. 2020 Nov 4;10(66):40244-40263. doi: 10.1039/d0ra08304f. eCollection 2020 Nov 2.
4
The use of minimal topological differences to inspire the design of novel tetrahydroisoquinoline analogues with antimalarial activity.利用最小拓扑差异来启发具有抗疟活性的新型四氢异喹啉类似物的设计。
Heliyon. 2021 May 21;7(5):e07032. doi: 10.1016/j.heliyon.2021.e07032. eCollection 2021 May.
5
Structure-Based Design and in Silico Screening of Virtual Combinatorial Library of Benzamides Inhibiting 2-trans Enoyl-Acyl Carrier Protein Reductase of with Favorable Predicted Pharmacokinetic Profiles.基于结构的设计和虚拟组合文库的计算机筛选苯甲酰胺抑制 2-反式烯酰基辅酶 A 还原酶与有利的预测药代动力学特征。
Int J Mol Sci. 2019 Sep 24;20(19):4730. doi: 10.3390/ijms20194730.
6
Plasmodium dihydrofolate reductase is a second enzyme target for the antimalarial action of triclosan.疟原虫二氢叶酸还原酶是三氯生抗疟作用的第二个酶靶标。
Sci Rep. 2018 Jan 18;8(1):1038. doi: 10.1038/s41598-018-19549-x.
7
How accurate is the description of ligand-protein interactions by a hybrid QM/MM approach?混合量子力学/分子力学方法对配体-蛋白相互作用的描述有多准确?
J Mol Model. 2017 Dec 12;24(1):11. doi: 10.1007/s00894-017-3537-z.
8
In silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitors.恶性疟原虫烯脂酰-ACP还原酶抑制剂的计算机筛选
J Comput Aided Mol Des. 2015 Jan;29(1):79-87. doi: 10.1007/s10822-014-9806-3. Epub 2014 Oct 25.
9
Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase.雷公藤红素抑制恶性疟原虫烯脂酰-酰基载体蛋白还原酶。
Bioorg Med Chem. 2014 Nov 1;22(21):6053-6061. doi: 10.1016/j.bmc.2014.09.002. Epub 2014 Sep 15.
10
Novel diaryl ureas with efficacy in a mouse model of malaria.具有抗疟疾小鼠模型疗效的新型二芳基脲类化合物。
Bioorg Med Chem Lett. 2013 Feb 15;23(4):1022-5. doi: 10.1016/j.bmcl.2012.12.022. Epub 2012 Dec 20.